Chemoinformaics analysis of 1,2-Dimethyl-3-vinyl-1,4-cyclohexadiene
| Molecular Weight | 134.222 | nRot | 1 |
| Heavy Atom Molecular Weight | 120.11 | nRig | 7 |
| Exact Molecular Weight | 134.11 | nRing | 1 |
| Solubility: LogS | -3.024 | nHRing | 0 |
| Solubility: LogP | 3.306 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 26.0351 |
| nHD | 0 | BPOL | 14.0449 |
| QED | 0.483 |
| Synth | 4.339 |
| Natural Product Likeliness | 1.586 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.004 |
| HIA | 0.004 |
| CACO-2 | -4.368 |
| MDCK | 0.000028 |
| BBB | 0.46 |
| PPB | 0.930276 |
| VDSS | 2.624 |
| FU | 0.0519174 |
| CYP1A2-inh | 0.696 |
| CYP1A2-sub | 0.913 |
| CYP2c19-inh | 0.503 |
| CYP2c19-sub | 0.869 |
| CYP2c9-inh | 0.099 |
| CYP2c9-sub | 0.567 |
| CYP2d6-inh | 0.067 |
| CYP2d6-sub | 0.746 |
| CYP3a4-inh | 0.689 |
| CYP3a4-sub | 0.306 |
| CL | 9.093 |
| T12 | 0.412 |
| hERG | 0.003 |
| Ames | 0.02 |
| ROA | 0.052 |
| SkinSen | 0.045 |
| Carcinogencity | 0.105 |
| EI | 0.588 |
| Respiratory | 0.102 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.950161 |